(1 - 24 von 26
)
Innovation Day | kurier.atkurier.at › wirtschaft › innovation-day
kurier.at
· „Unsere Medizinalchemiker sind dabei zugleich Architekten und Handwerker dieser Arzneimittel“, erklärt Boehringer-Experte Darryl McConnell.
Philogen Enters into Multi-Target Research Agreement with Boehringer...
www.eleconomista.es
Darryl McConnell, Vice President and Head, Boehringer Ingelheim Research Site Austria, said, “We are very excited about the opportunity to apply ...
EuroMillions jackpot winner Margaret Loughrey to spread her good...
www.belfasttelegraph.co.uk
The winner of Northern Ireland’s largest ever Lottery prize has vowed to use her new-found wealth to help others.
Veranstaltungen - FCIO Websitewww.fcio.at › aktuelles › veranstaltungen
www.fcio.at
Über den gleichen Feind, aber über ein anderes Mittel zu dessen Bekämpfung, berichtete Darryl McConnell in seinem Vortrag: Bei Boehringer Ingelheim sucht er ...
Bild: Philipp von Lattorf und Darryl McConnell | Boehringer Ingelheim...
www.ots.at
Philipp von Lattorf und Darryl McConnell von Boehringer Ingelheim
PHILOGEN GIBT ZUSAMMENARBEIT MIT BOEHRINGER INGELHEIM IM RAHMEN EINES...
www.finanznachrichten.de
Philogen S.p.A., ein im Privatbesitz befindliches Biotechnologieunternehmen, gab heute eine Zusammenarbeit und Lizenzvereinbarung mit Boehringer Ingelheim...
Philogen S.p.A.. ( ). "Press Release: Philogen Enters into...
www.life-sciences-europe.com
Life Sciences Business Intelligence Web Portal for European countries
Patients, Advocates, Researchers Come Together to Kick Cancer's ...www.finanzen.net › Aktien
www.finanzen.net
· Darryl McConnell, Ph.D., Senior Vice President and Research Site Head at Boehringer-Ingelheim Regional Centre Vienna, Austria, ...
Boehringer Ingelheim Regional Center Vienna mit Rekordergebnis |...
www.ots.at
Darryl McConnell, Forschungsleiter im Boehringer Ingelheim RCV. Wien (OTS)-• Wachstum in allen Geschäftsbereichen • Betriebsleistung steigt auf EUR ,1 Mio.
Philogen Enters into Multi-Target Research Agreement with Boehringer...
www.finanznachrichten.de
Philogen S.p.A., a privately owned biotechnology company today announced a collaboration and license agreement with Boehringer Ingelheim to discover and...
Boehringer Ingelheim baut Standort Wien aus – mnews – medianet.at
medianet.at
Der Pharmakonzern Boehringer Ingelheim investiert in Wien 700 Mio. € und setzt hier auf Biotechnologie.
Gutes Geschäftsjahr für das Boehringer Ingelheim RCV |...
www.ots.at
2020 war für alle Unternehmen ein sehr herausforderndes Jahr.
Boehringer Ingelheim and Vanderbilt University expand partnership to...
news.vumc.org
... proteins KRAS, SOS and now, MCL1,” said Darryl McConnell, Ph.D., Vice President and Research Site Head, Boehringer Ingelheim, Austria.
Co Down men win over £1m in Lotto - The Irish Timeswww.irishtimes.com › news
www.irishtimes.com
A Northern Ireland man, who is unemployed, also did well in the latest British lottery draw. Mr Darryl McConnell (23), of Dunmurry, Belfast, netted £1.3 million ...
Boehringer Ingelheim forciert immunonkologische Forschung
www.lisavienna.at
Neues Forschungsgebäude eröffnet Kombinierte Therapie mit Fokus auf Krebszelle und Immunzelle Neue...
CMO Serialisation Seminar - FMD Readiness for Contract Packing Sector
www.codico-distributors.com
Darryl McConnell, Serialisation Technical Lead at Almac Group – Serialisation CMO Case Study: Addressing counterfeiting and facilitating ...
Boehringer Ingelheim investiert in Krebsforschungszentrum in Wienwww.lisavienna.at › news › boehringer-ingelheim-investiert-in-krebsforsch...
www.lisavienna.at
· Darryl McConnell, Forschungsleiter bei Boehringer Ingelheim RCV. „Mit jährlich 200 Millionen Euro Forschungsaufwendungen zählt Boehringer ...
Partnership extended to develop novel anti-cancer drugs targeting...
... MCL1,” said Darryl McConnell, PhD, vice president and research site head, Boehringer Ingelheim, Austria. “Together, we are committed to ...
Boehringer Ingelheim, Vanderbilt Expand Partnership | Contract Pharma
www.contractpharma.com
To focus on the discovery and development of new chemical the…utics targeting certain cancers
Just released: Taking Cancer On - the podcastwaroncancer.com › news › taking-cancer-on-the-po...
waroncancer.com
· Expert Guest: Dr Darryl McConnell, Senior Vice President and Research Site Head for Boehringer Ingelheim, Austria.
PAREXEL, Vanderbilt University, Boehringer Ingelheim, And Morewww.bio-itworld.com › › parexel-vand...
www.bio-itworld.com
· ... SOS and now, MCL1,” said Darryl McConnell, Vice President and Research Site Head, Boehringer Ingelheim, Austria, in a press release.
Boehringer Ingelheim and University of Dundee highlight successful ...www.dundee.ac.uk › stories › boehringer-ingelheim...
www.dundee.ac.uk
· Our collaboration will continue to work to bring this new class of medicines to patients,” said Darryl B. McConnell, PhD, Senior Vice President ...
Targeting KRAS for potential cancer treatment | EurekAlert!
www.eurekalert.org
· Article # : "Drugging an undruggable pocket on KRAS," by Dirk Kessler et al. MEDIA CONTACT: Darryl Benjamin McConnell, Boehringer ...
write of reply : Science by degrees | New Scientist
www.newscientist.com
Sydney I sympathise with students such as Matthew Lay (write of reply, 1 March) who suffer from a severe lack by Darryl McConnell. Magazine issue
sortiert nach Relevanz / Datum